CVS Health (CVS) Tops Q3 EPS by 33c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Alphabet shares drop ahead of earnings next week
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
CVS Health Reports Third Quarter Results With Diversified Assets Delivering Strong Enterprise Performance
November 6, 2020 6:30 AM ESTWOONSOCKET, R.I., Nov. 6, 2020 /PRNewswire/ --
Continued Responsiveness to COVID-19:
Ongoing support for employees, consumers and communities across the country Doubled the number of test sites to more than 4,000 CVS Pharmacy locations nationwide Selected to administer vaccines to long-term care facilities Consumer-driven health care model increases access to products and servicesThird Quarter Highlights:
Total revenues increased to $67.1 billion, up 3.5% compared to prior year GAAP diluted earnings per share of $0.93 and GAAP operating income of $3.2 billion Adjusted EPS... More


